The company takes stock of the work in the first quarter and puts forward the work requirements for the second quarter.
Release time:
2020-08-14
Company Counts Work in the First Quarter and Proposes Work Requirements for the Second Quarter
News 4# July 17 and 18 , the Company successively held work analysis meetings for cement sector, pharmaceutical industry, international trade and cable companies to summarize the gains and losses of the work in the first quarter and put forward requirements for the next stage, especially the work in the second quarter. At the
analysis meeting, the person in charge of each enterprise reported the work situation in the first quarter in the form of PPT , focusing on analyzing the existing problems and proposing solutions and improvement plans. Chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one based on the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements.
Cement Plate: Optimize Structure, Improve Efficiency, Insist on Maximizing Benefits
In the first quarter, the overall benefits of the two peak cement enterprises increased year on year. Removing the factor of rising coal prices, various production indicators such as kiln production, cement mill production and power consumption per ton of clinker were improved, and the optimization of management organizations and posts was also steadily advancing. The company leaders pointed out that the future competition in the cement industry will be more cruel. Jianfeng Cement must clarify its thinking, seize the current more favorable opportunity, strengthen its own strength, adhere to the principle of maximizing benefits, strengthen the construction of core profit areas, and strive to achieve a balance of production and sales while striving for Greater profit space. The
meeting required the two cement companies to adjust the balance between the product structure and the target market in terms of sales according to the actual situation of the company and the development trend of the cement industry in the region, so as to improve the comprehensive gross profit and lay a good foundation for the continued stability of the market in the future. In terms of internal management, while strengthening the optimization of institutions and posts, carefully sort out and improve the functions and responsibilities of departments, teams and posts, and standardize the work process and work standards in detail; combine internal training with external training, strengthen the training of employees' knowledge of cement production technology and equipment, and comprehensively improve the overall quality of employees; strengthen equipment maintenance and management, equipment maintenance standards, procurement and storage of spare parts, and equipment replacement cycles must be strictly and scientifically controlled, and problems must be deeply summarized to effectively improve the reliability and stability of equipment operation; strengthen technical research and technological transformation, and continue to introduce And use new technologies to further optimize and improve various production indicators; improve the implementation of responsibilities and evaluation incentive mechanisms, ensure that every control index and the requirements of every production link can be consciously implemented in the post, so that the work is consistent with the evaluation and assessment, and the enthusiasm of the whole staff is improved. In terms of environmental protection and safety management, it is necessary to eliminate fluke mentality, earnestly implement the safety and environmental protection responsibility system at all levels, increase investment in related facilities, equipment and technical transformation, strengthen self-inspection and self-correction of habitual violations, and earnestly implement the hazardous environment operation ticket system. Optimize the actual situation and revise and improve the safety work procedures to ensure safe and orderly production.
According to the specific conditions of the two enterprises, the company leaders also requested Daye Peak to further strengthen daily inspection and maintenance to avoid overload operation of equipment and reduce unstable factors affecting production. Yunnan Peak should adjust its sales strategy in rainy season in advance to ensure the balance of production and sales and market stability.
Peak Pharmaceutical Industry: Finding Gaps, Setting Benchmarks, Brave Innovation, Seeking Breakthrough
With the further deepening of medical system reform, drug consistency evaluation and the implementation of the "two-vote system", the production and operation of pharmaceutical enterprises are facing many new pressures. At the analysis meeting, the company leaders asked the pharmaceutical company to recognize the policy changes and the development trend of the industry, seriously think about the future work with a higher height, wider vision and longer-term vision, deeply analyze the gap with the advanced enterprises in the same industry, select the benchmark, solve their own shortcomings and problems point to point, and seek breakthroughs.
In terms of sales, we must boldly innovate marketing mechanisms and methods, boldly use talents, give full play to the enthusiasm of sales staff, increase assessment efforts, carry out precise incentives, and seek sales breakthroughs; according to the specific conditions of each product, Do a good job of bidding with the idea of long-term benefit planning to lay the foundation for market expansion and product volume. In terms of production, we should firmly establish the purpose of serving all for sales, pay close attention to cost management on the premise of ensuring quality, and strive to reduce production costs by improving the yield, one-time pass rate and quality rate. In terms of product development, boldly introduce new varieties with market and technical advantages, and accelerate the promotion of consistency evaluation and other related work. In terms of internal management, we should make forward-looking information investment, improve the level of information construction, and improve operational efficiency; boldly employ new people, train, select and enrich the talent team; continue to promote the optimization of internal management structure and team building, and strive to innovate in working ideas and working methods, so as to realize the self-improvement and transformation of the team. In terms of project promotion, accelerate the implementation of international certification, Jinder, artificial bezoar and other work, and pay close attention to and track the operation of Huibaoyuan and other enterprises. The meeting also asked pharmaceutical companies to implement the division of labor and clear responsibilities from the members of the management team, so as to make the whole organizational structure operate more smoothly and efficiently.
International Trade Company: Find the correct positioning and development direction, strengthen management, and improve service quality
Company leadership requirements, international trade companies must clarify the goal and direction of "modern logistics", and combine the actual situation of the company, Carry out various tasks in a targeted manner, form a business model with advantages and own characteristics, and strengthen the construction of a talent team that is compatible with its own positioning; on the existing basis, continue to improve old business, expand new business, and extend the business chain; strengthen internal management, improve management standardization, and improve service quality; strengthen the cultivation of sense of responsibility and mission, reduce management levels, implement precise incentives, and give full play to The enthusiasm of employees; sort out and formulate various systems based on the principles of operability and efficiency, eliminate management loopholes, and reduce operating costs.
Peak Cable: Thrift and Thrift, Maintain Stability
Cable Company's overall production and operation in the first quarter was stable. The company's leaders required the management team to do a good job in the management of assets, personnel, safe production and receivables, organize and carry out various tasks such as procurement, production and sales with the idea of "thrifty and thrifty", strive to reduce production costs and lay a good foundation for future transformation.
The first quarter job analysis meeting of Spike Health Technology will be held at a later date. (Reporter Fu Yiwu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31